Literature DB >> 19944213

Partial splenectomy prevents splenic sequestration crises in sickle cell disease.

Laura R Vick1, John R Gosche, Saleem Islam.   

Abstract

PURPOSE: Acute splenic sequestrations (SSs) are potentially fatal complications in sickle cell disease (SCD). Total splenectomies in young patients may predispose them to a higher risk of overwhelming infections, whereas partial splenectomy may maintain immunocompetence. We present our series of partial splenectomies in patients with multiple SS episodes.
METHODS: We retrospectively reviewed the records of 6 patients who underwent open partial splenectomies for SS. Data on their clinical courses were collected and analyzed.
RESULTS: None of the 6 patients had SS postprocedure, down from 2.1 +/- 1.0 (P = .003) sequestrations per year and 3.5 +/- 1.4 (P = .002) total sequestrations per patient. The transfusion requirements were significantly reduced postoperatively (10.2 +/- 5.6 vs 2.0 +/- 3.1 per year; P = .002). There was no increase in the infection-related hospital admissions during the period of follow-up (1.5 +/- 1.8 vs 0.8 +/- 0.8 per year after partial splenectomy; P = .363). The upper pole was preserved in all cases with blood supply off the main splenic artery.
CONCLUSIONS: Partial splenectomy decreases the risk of SS in SCD and reduces the need for blood transfusions. Infection rates did not increase after the procedure during the follow-up period. Partial splenectomy should be considered for patients who experience multiple acute SS crises or have long-term transfusion requirements.

Entities:  

Mesh:

Year:  2009        PMID: 19944213     DOI: 10.1016/j.jpedsurg.2009.06.007

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  Evaluation of partial and total splenectomy in children with sickle cell disease using an Internet-based registry.

Authors:  Sofia Mouttalib; Henry E Rice; Denise Snyder; Justin S Levens; Audra Reiter; Pauline Soler; Jennifer A Rothman; Courtney D Thornburg
Journal:  Pediatr Blood Cancer       Date:  2012-01-11       Impact factor: 3.167

2.  Clinical events after surgical splenectomy in children with sickle cell anemia.

Authors:  Ram Kalpatthi; Ian D Kane; Ibrahim F Shatat; Betsy Rackoff; Deborah Disco; Sherron M Jackson
Journal:  Pediatr Surg Int       Date:  2010-03-23       Impact factor: 1.827

3.  Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks.

Authors:  San D Keller; Manshu Yang; Marsha J Treadwell; Ellen M Werner; Kathryn L Hassell
Journal:  Health Qual Life Outcomes       Date:  2014-08-22       Impact factor: 3.186

4.  Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠.

Authors:  San Keller; Manshu Yang; Marsha J Treadwell; Kathryn L Hassell
Journal:  Health Qual Life Outcomes       Date:  2017-06-02       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.